# CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer

> **NCT03359668** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 47 (actual)

## Conditions studied

- Papillary Thyroid Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Use of IV contrast during head and neck CT

## Key facts

- **NCT ID:** NCT03359668
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-28
- **Primary completion:** 2017-04-20
- **Final completion:** 2017-04-20
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359668, "CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03359668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
